Responding to FDA Form 483s and Warning Letters - Webinar By ComplianceOnline

This training on responding to FDA Form 483s and Warning Letters will present methods for reviewing, evaluating, and writing responses to FDA Form 483s and Warning Letters.
 
 
ComplianceOnline 2011
ComplianceOnline 2011
Aug. 11, 2011 - PRLog -- Why Should You Attend:

FDA Form 483s are used to document the findings of FDA investigators or other FDA authorized inspectors after their inspection and evaluation of manufacturing and control practices associated with FDA-regulated products. Warning Letters are issued to top management of FDA-regulated companies following inspections in which the agency determines that serious violations have occurred.

Proper interpretation and understanding of the contents and phrasing of FDA Form 483 observations and Warning Letters is critical to preparing effective responses and post-inspection plans.

This course will provide examples to illustrate good techniques in reviewing and responding to FDA Form 483s and Warning Letters.

Learning Objectives:

- Understanding of FDA Form 483
- Understanding of Warning Letter
- Tips for developing effective responses
- Tips for writing effective responses

For More Details: qpgfh
http://complianceonline.com/ecommerce/control/trainingFoc...

NOTE : Add another webinar to your shopping cart and get 20% off on its price.

# # #

Enhancing global compliance, creating a world where quality and compliance professionals, regulators, and government agencies come together to help the world comply with the intent and the spirit of laws, policies and mandates.
End
Source:
Email:***@complianceonline.com Email Verified
Phone:+1-650-620-3915
Zip:94303
Tags:FDA investigator, Regulatory Compliance Training, Corporate Compliance Training
Industry:Education, Event
Location:Palo Alto - California - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
ComplianceOnline News
Trending
Daily News
Weekly News



Like PRLog?
9K2K1K
Click to Share